Icotinib Combined With WBRT For NSCLC Patients With Brain Metastases and EGFR Mutation

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Betta Pharmaceuticals Co.,Ltd.
ClinicalTrials.gov Identifier:
NCT01516983
First received: January 10, 2012
Last updated: February 13, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)